Our Products

Afatinib Tablets 20 mg is a targeted therapy medication used primarily to treat non-small cell lung cancer (NSCLC) that is positive for specific genetic mutations, such as EGFR (epidermal growth factor receptor) mutations. Afatinib is a tyrosine kinase inhibitor that works by blocking the activity of the EGFR and other related receptors, which are involved in cancer cell growth. By inhibiting these receptors, Afatinib helps to slow or stop the growth of cancer cells that depend on them for survival.

The 20 mg dosage is typically taken once daily, with or without food, as prescribed by a healthcare provider. Common side effects may include diarrhea, skin rash, mouth sores, fatigue, and liver enzyme abnormalities. Regular monitoring of liver function, as well as managing gastrointestinal symptoms and skin reactions, is important during treatment to ensure the drug’s effectiveness and to address any potential side effects.